Beijing Strong Biotechnologies, Inc. (300406.SZ) has obtained a medical device registration certificate.
Jiuchang Bio (300406.SZ) announced that the company recently received a "..." issued by the Beijing Municipal Drug Administration...
Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that the company has recently received a Medical Device Registration Certificate from the Beijing Municipal Drug Administration for its product: Digoxin Assay Kit (magnetic particle chemiluminescence immunoassay). This kit is used for quantitative determination of digoxin (DIG) content in human serum or plasma.
The acquisition of the mentioned product's medical device registration certificate enriches the company's product line in the field of in vitro diagnostic chemiluminescence, which will help enhance the company's core competitiveness and market expansion capabilities. This will have a positive impact on the company's future operations.
Related Articles

US Stock Market Move | Taiwan liquor merchant Agencia Comercial Spirits (AGCC.US) landed on the US stock market, opening with a rise of over 4.7%.

US Stock Market Move | Net Plastic Technology (NPT.US) debuts on the US stock market, triggering a circuit breaker after the opening.

US Stock Market Move | Chip stocks generally fell, with Intel Corporation (INTC.US) falling over 4%.
US Stock Market Move | Taiwan liquor merchant Agencia Comercial Spirits (AGCC.US) landed on the US stock market, opening with a rise of over 4.7%.

US Stock Market Move | Net Plastic Technology (NPT.US) debuts on the US stock market, triggering a circuit breaker after the opening.

US Stock Market Move | Chip stocks generally fell, with Intel Corporation (INTC.US) falling over 4%.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025